soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm

soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm The (Semaglutide Trial) was a randomized SOUL Trial (NEJM 2025): Oral

Name: soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm The (Semaglutide Trial) was a randomized SOUL Trial (NEJM 2025): Oral
Brand: 2m-capital.com
SKU: 54800770867
Price: 28.00 USD
Availability: InStock
Rating: 4.3375 (22 reviews)

SKU: 54800770867

4.3

USD28.00 USD71.00

Pay in 4 interest-free payments of $7.00 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 11 - Nov 16

Description

Adults with a BMI 30 or 27 with weight-related conditions

Tirzepatide clinical trial results The SURMOUNT-1 trial tested tirzepatide in adults with obesity or overweight without type 2 diabetes

For a 5 mg vial reconstituted at 2.5 mg/mL (2 mL total), a weekly dose of 0.5 mg (20 units) gives you 10 doses per vial

Some early research suggests that GLP-1 medications might have a positive effect on mood or anxiety, potentially through the gut-brain connection, explains Salhab